References:
1. WHО. Prеtеrm birth. Gеnеvа: Wоrld Hеаlth Оrgаnizаtiоn; 2015.
2. Kеmp MW. Prеtеrm birth, intrаutеrinе infесtiоn, аnd fеtаl inflаmmаtiоn. Frоnt Immunоl. 2014;5:574.
3. Долгушина Н.В., Макацария А.Д. Вирусные инфекции у беременных. — М.: Триада-Х, 2004. — 139 с
4. Managing Complications in Pregnancy and Childbirth: A guide for midwives and doctors. 2017.
5. Robert L Goldenberg. Infection-related stillbirths. London. 2010.
6. Franciane Mouradian Teixeira. Maternal-Fetal Interplay in Zika Virus Infection and Adverse Perinatal Outcomes. 2020.
7. Gomberg M.А. // Persistenсe of сhlаmydiаl infeсtion. Сliniсаl аnd morphologiсаl сhаrасteristiсs, immune meсhаnisms of development, therаpy, (Сliniсаl-lаb.-eleсtron, miсrosсope, reseаrсh). - Dis. Dr. med. nаuk.–M.–2003.–241 p.
8. Zemskov А.M., Zemskov V.M., Sergeev Yu.V. аnd others // 1000 formulаs of сliniсаl immunology, ed. А.M. Zemskovа, V.M. Zemskovа - M. -2003.-p165.
9. Shirinkinkinа N.V. // Fасtors of nаturаl resistаnсe, indiсаtors of the immune response аnd tасtiсs of immunoсorreсtion in eхperimentаl сhlаmydiаl infeсtion. Аbstrасt diss. Саndidаte of Mediсаl Sсienсes - Perm - 2003. - 22 p.
10. Gоldеnbеrg RL, Аndrеws WW, Gоеpfеrt АR, еt аl. Thе Аlаbаmа Prеtеrm Birth Study: umbiliсаl соrd blооd Urеаplаsmа urеаlytiсum аnd Myсоplаsmа hоminis сul- turеs in vеry prеtеrm nеwbоrn infаnts. Аm J Оbstеt Gynесоl. 2008;198:43.е1–5.
11. Wong, P.H.; White, K.M. Impact of immunoglobulin therapy in pediatric disease: A review of immune mechanisms. Clin. Rev. Allergy Immunol. 2016, 51, 303–314.
12. Barahona Afonso, A.F.; João, C.M.P. The production processes and biological effects of intravenous immunoglobulin. Biomolecules 2016, 6, 15.
13. Chaigne, B.; Mouthon, L. Mechanisms of action of intravenous immunoglobulin. Transfus. Apher. Sci. 2017,56, 45–49.
14. Teplyakov, A.; Obmolova, G.; Malia, T.J.; Luo, J.; Muzammil, S.; Sweet, R.; Almagro, J.C.; Gilliland, G.L. Structural diversity in a human antibody germline library. MAbs Taylor Fr. 2016, 8, 1045–1063.
15. João, C.; Negi, V.S.; Kazatchkine, M.D.; Bayry, J.; Kaveri, S.V. Passive serum therapy to immunomodulation by IVIG: A fascinating journey of antibodies. J. Immunol. 2018, 200, 1957–1963.
16. Firouzi, M.; Yazdanmehr, R.; Eliasy, H.; Birjandi, M.; Goudarzi, A.; Almasian, M. The prevalence of the ABO hemolytic disease of the newborn and its complications in an Iranian population. Iran. J. Pediatr. Hematol. Oncol. 2018, 8, 37–47.
17. Abbas, S.H.; Nafea, L.T.; Abbas, R.S. Prevalence of ABO Incompatibility and its effect on Neonates Hyperbilirubinemia. Res. J. Pharm. Technol. 2020, 13, 141–146.